|
Name |
Colchiceinamid
|
Molecular Formula | C21H24N2O5 | |
IUPAC Name* |
N-[(7S)-10-amino-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
|
|
SMILES |
CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)N)OC)OC)OC
|
|
InChI |
InChI=1S/C21H24N2O5/c1-11(24)23-16-8-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-7-15(22)17(25)10-14(13)16/h6-7,9-10,16H,5,8H2,1-4H3,(H2,22,25)(H,23,24)/t16-/m0/s1
|
|
InChIKey |
JWDFWIZNGSOUGC-INIZCTEOSA-N
|
|
Synonyms |
Colchiceinamid; Colchiceinamide; Colchicine amide; Colchicamide; Colchicamid; 3123-89-5; Colchicide, 14-amino-; SKF 3192; COLCHICINE, 10-AMINO-10-DEMETHOXY-; N-[(7S)-10-amino-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide; Colchicenamide; 14-Aminocolchicide; Colchicamide (VAN); Colchiceeinamide; Colchiceeinamide [German]; Acetamide,N-[(7S)-10-amino-5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo[a]heptalen-7-yl]-; NSC 403144; BRN 2824077; 4-14-00-00921 (Beilstein Handbook Reference); Acetamide, N-(10-amino-5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-; Colchicamide (colchiceinamide); CHEMBL357889; SCHEMBL12118701; DTXSID00185149; ZINC4025798; MFCD25368469; NSC403144; STL530408; AKOS030489333; NSC-403144; Acetamide,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)-; N-[(7S)-10-amino-1,2,3-trimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
|
|
CAS | 3123-89-5 | |
PubChem CID | 18397 | |
ChEMBL ID | CHEMBL357889 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 384.4 | ALogp: | 0.3 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 99.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 28 | QED Weighted: | 0.84 |
Caco-2 Permeability: | -4.869 | MDCK Permeability: | 0.00000765 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.481 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.015 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.93 | Plasma Protein Binding (PPB): | 82.43% |
Volume Distribution (VD): | 0.866 | Fu: | 12.88% |
CYP1A2-inhibitor: | 0.415 | CYP1A2-substrate: | 0.897 |
CYP2C19-inhibitor: | 0.032 | CYP2C19-substrate: | 0.823 |
CYP2C9-inhibitor: | 0.018 | CYP2C9-substrate: | 0.6 |
CYP2D6-inhibitor: | 0.163 | CYP2D6-substrate: | 0.641 |
CYP3A4-inhibitor: | 0.238 | CYP3A4-substrate: | 0.88 |
Clearance (CL): | 4.071 | Half-life (T1/2): | 0.879 |
hERG Blockers: | 0.091 | Human Hepatotoxicity (H-HT): | 0.91 |
Drug-inuced Liver Injury (DILI): | 0.167 | AMES Toxicity: | 0.132 |
Rat Oral Acute Toxicity: | 0.617 | Maximum Recommended Daily Dose: | 0.325 |
Skin Sensitization: | 0.075 | Carcinogencity: | 0.066 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.212 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001403 | 0.620 | D09DHY | 0.826 | ||||
ENC005314 | 0.402 | D02LZB | 0.689 | ||||
ENC005522 | 0.352 | D04TDQ | 0.361 | ||||
ENC001571 | 0.345 | D01FFA | 0.360 | ||||
ENC003548 | 0.336 | D0Y7TS | 0.333 | ||||
ENC002404 | 0.336 | D0L1JW | 0.331 | ||||
ENC005867 | 0.336 | D06GCK | 0.327 | ||||
ENC000701 | 0.331 | D0F7CS | 0.314 | ||||
ENC005980 | 0.330 | D0D4HN | 0.306 | ||||
ENC001396 | 0.330 | D0A8FB | 0.303 |